Biphasic dose-related effects of morphine on dopamine release

Drug and Alcohol Dependence

Volumn 65, Issue 1, 2001, Pages 55-63

  Maisonneuve, Isabelle M ^a   Warner, Laurie M ^a   Glick, Stanley D ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Dopamine; Microdialysis; Morphine; Nucleus accumbens; Striatum

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; HOMOVANILLIC ACID; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG MECHANISM; FEMALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; ANALGESICS, OPIOID; ANIMALS; CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SPACE; FEMALE; HOMOVANILLIC ACID; MORPHINE; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; STEREOTAXIC TECHNIQUES;

EID: 0035575463     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(01)00150-8     Document Type: Article

References (53)

1. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex
2. 3-preferring ligands act at synthesis modulating autoreceptors
3. The neurosteroid pregnenolone sulphate increases dopamine release and the dopaminergic response to morphine in the rat nucleus accumbens
4. Involvement of mu- and delta-opioid receptors in the effects of systemic and locally perfused morphine on extracellular levels of dopamine, DOPAC and HVA in the nucleus accumbens of the halothane-anaesthetized rat
5. Intracranial self-administration of morphine into the ventral tegmental area in rats
6. Involvement of the ventral tegmental dopamine system in opioid and psychomotor stimulant reinforcement
7. Facilitation of self-stimulation behavior following intracerebral microinjections of opioids into the ventral tegmental area
8. Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine
9. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats
10. Orphanin FQ reduces morphine-induced dopamine release in the nucleus accumbens: A microdialysis study in rats
11. Lack of an effect of 6-hydroxydopamine lesions of the nucleus accumbens on intravenous morphine self-administration
12. Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine
13. Effect of nucleus accumbens dopamine depletion on motivational aspects involved in initiation of cocaine and heroin self-administration in rats
14. Effects of cocaine and morphine in rats from two psychogenetically selected lines: A behavioral and brain dialysis study
15. (±)-18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: Effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats
16. 18-Methoxycoronaridine: A novel iboga alkaloid congener having potential anti-addictive efficacy
17. Morphine-induced activation of A10 dopamine neurons in the rat
18. Control of glutamate release by calcium channels and kappa-opioid receptors in rodent and primate striatum
19. Opioids excite dopamine neurons by hyperpolarization of local interneurons
20. Handling and/or saline injections alter basal and morphine-evoked changes in dopamine metabolites in the striatum and nucleus accumbens of rats
21. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence
22. Modulation of A10 dopamine neurons by gamma-aminobutyric acid agonists
23. Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity
24. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: An in vivo microdialysis study
25. The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine
26. Two cell types in rat substantia nigra zona compacta distinguished by membrane properties and the actions of dopamine and opioids
27. Morphine-dopamine interaction: Ventral tegmental morphine increases nucleus accumbens dopamine release
28. Attenuation of the reinforcing efficacy of morphine by 18-methoxycoronaridine
29. Interactions between ibogaine, a potential anti-addictive agent, and morphine: An in vivo microdialysis study
30. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors
31. Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS
32. Update on dopamine receptors
33. Immunohistochemical localization of the cloned kappa 1 receptor in the rat CNS and pituitary
34. Cloning and pharmacological characterization of a rat kappa opioid receptor
35. Kappa opioid receptor immunoreactivity in the nucleus accumbens and caudate-putamen is primarily associated with synaptic vesicles in axons
36. Affinity profiles of morphine, codeine, dihydrocodeine and their glucuronides at opioid receptor subtypes
37. Dopamine D3 receptor antisense influences dopamine synthesis in rat brain
38. Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats
39. Involvement of opioid mu1-receptors in opioid-induced acceleration of striatal and limbic dopaminergic transmission
40. Characterization of the decrease of extracellular striatal dopamine induced by intrastriatal morphine administration
41. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the 'shell' as compared with the 'core' of the rat nucleus accumbens
42. Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment
43. Systemic morphine simultaneously decreases extracellular acetylcholine and increases dopamine in the nucleus accumbens of freely moving rats
44. Effects of aging on the interaction between glutamate, dopamine, and GABA in striatum and nucleus accumbens of the awake rat
45. Strain differences in the rewarding and dopamine-releasing effects of morphine in rats
46. Effects of 6-OHDA lesions in the nucleus accumbens on the acquisition of self injection of heroin under schedule and non schedule conditions in rats
47. Effects of 6-OHDA lesions of the central medial nucleus accumbens on rat intravenous morphine self-administration
48. kappa-Opioid inhibition of [3H]dopamine release from rat ventral mesencephalic dissociated cell cultures
49. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway
50. The potential anti-addictive agent, 18-methoxycoronaridine, blocks the sensitized locomotor and dopamine responses produced by repeated morphine treatment
51. Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens
52. Dopamine release in the nucleus accumbens during heroin self-administration is modulated by Kappa opioid receptors: An in vivo fast-cyclic voltamemetry study